(Q44416638)

2 December 2017

Design, synthesis and biological evaluation of oxazolidinone-quinolone hybrids (English)

1 reference

2 December 2017

Design, Synthesis and Biological Evaluation of Oxazolidinone–Quinolone Hybrids (English)

1 reference

https://api.crossref.org/works/10.1016/S0968-0896(03)00083-X

27 December 2023

1 reference

https://api.crossref.org/works/10.1016/S0968-0896(03)00083-X

27 December 2023

pharmaceutical science

1 reference

https://api.crossref.org/works/10.1016/S0968-0896(03)00083-X

27 December 2023

1 reference

https://api.crossref.org/works/10.1016/S0968-0896(03)00083-X

27 December 2023

1 reference

https://api.crossref.org/works/10.1016/S0968-0896(03)00083-X

27 December 2023

author name string

Christian Hubschwerlen

1

1 reference

2 December 2017

Jean Luc Specklin

2

1 reference

2 December 2017

Christine Sigwalt

3

1 reference

2 December 2017

Susanne Schroeder

4

1 reference

2 December 2017

Hans H. Locher

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12713843

27 December 2023

language of work or name

English

0 references

publication date

1 May 2003

1 reference

2 December 2017

15 May 2003

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=12713843

full work available at URL

27 December 2023

https://api.elsevier.com/content/article/PII:S096808960300083X?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/S0968-0896(03)00083-X

https://api.elsevier.com/content/article/PII:S096808960300083X?httpAccept=text/plain

27 December 2023

1 reference

https://api.crossref.org/works/10.1016/S0968-0896(03)00083-X

Bioorganic & Medicinal Chemistry

27 December 2023

published in

1 reference

2 December 2017

11

1 reference

2 December 2017

2313-2319

1 reference

2 December 2017

10

1 reference

Linezolid resistance in a clinical isolate of Staphylococcus aureus

2 December 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2803%2900083-X

7 January 2021

In-vitro activity of new sulphanilil fluoroquinolones against Staphylococcus aureus.

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2803%2900083-X

7 January 2021

Quinolone molecular structure-activity relationships: what we have learned about improving antimicrobial activity

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2803%2900083-X

7 January 2021

Structure-activity and structure-side-effect relationships for the quinolone antibacterials

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2803%2900083-X

7 January 2021

Synthesis and antibacterial activity of U-100592 and U-100766, two oxazolidinone antibacterial agents for the potential treatment of multidrug-resistant gram-positive bacterial infections

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2803%2900083-X

7 January 2021

Effect of pathological changes of pH, pO2 and pCO2 on the activity of antimicrobial agents in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2803%2900083-X

7 January 2021

Semisynthetic beta-lactam antibiotics. III. Synthesis and antibacterial activity of 7 beta-[2-(2-aminothiazol-4-yl)-2-(substituted carbamoylmethoxyimino)acetamido]cephalosporins

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2803%2900083-X

7 January 2021

Structure-activity relationship (SAR) studies on oxazolidinone antibacterial agents. 3. Synthesis and evaluation of 5-thiocarbamate oxazolidinones

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2803%2900083-X

7 January 2021

Structure-activity relationships of novel 2-substituted quinazoline antibacterial agents

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2803%2900083-X

7 January 2021

Tryptic fragments of the Escherichia coli DNA gyrase A protein.

23

1 reference

https://api.crossref.org/works/10.1016/S0968-0896(03)00083-X

Escherichia coli topoisomerase IV. Purification, characterization, subunit structure, and subunit interactions.

27 December 2023

24

1 reference

https://api.crossref.org/works/10.1016/S0968-0896(03)00083-X

27 December 2023

Identifiers

1 reference

2 December 2017

1 reference